biology

Pozelimab

Pozelimab is a biology topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Pozelimab rather than just read about it. In short: Pozelimab, sold under the brand name Veopoz, is a recombinant monoclonal antibody used for the treatment of CD55-deficient protein-losing enteropathy, also known as CHAPLE disease. Pozelimab is a complement inhibitor.

Key takeaways

Pozelimab belongs to biology; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Pozelimab to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Pozelimab from memory before moving on to harder problems.

Reference excerpt

Pozelimab, sold under the brand name Veopoz, is a recombinant monoclonal antibody used for the treatment of CD55-deficient protein-losing enteropathy, also known as CHAPLE disease. Pozelimab is a complement inhibitor. It is produced using recombinant DNA technology in Chinese hamster ovary cells. The most common adverse reactions include upper respiratory tract infections, fractures, hives, and alopecia. Pozelimab was approved for medical use in the United States in August 2023. It is the first FDA-approved treatment for CHAPLE disease. The US Food and Drug Administration (FDA) considers it to be a first-in-class medication.

Medical uses Pozelimab is indicated for the treatment of people with CD55-deficient protein-losing enteropathy, also known as CHAPLE disease. CHAPLE—which stands for complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy—is an inherited immune disease that causes the complement system (the part of your immune system that defends the body against injury and foreign invaders like bacteria and viruses) to become overactive. It is caused by mutations of the complement regulator CD55 gene, which can lead to the complement system attacking the body's own cells. CHAPLE disease is a rare disease, with fewer than 100 participants diagnosed worldwide. Symptoms can include abdominal pain, nausea, vomiting, diarrhea, loss of appetite, weight loss, impaired growth, and edema (swelling). Severe thrombotic vascular occlusions (blockage of blood vessels) can also occur among participants with CHAPLE disease, which can be life-threatening.

Adverse effects The US prescribing label for pozelimab has a boxed warning for serious meningococcal infections. The most common adverse reactions (in 2 or more patients) are upper respiratory tract infection, fracture, urticaria, and alopecia.

History The efficacy and safety of pozelimab was evaluated in a single-arm study (NCT04209634), in which participants' outcomes were compared to pre-treatment data in participants with active CD55-deficient protein-losing enteropathy who had hypoalbuminemia. Participants' diagnoses were based on a clinical history of protein-losing enteropathy symptoms and with a confirmed genotype of biallelic CD55 loss-of-function mutation. Active CD55-deficient protein-losing enteropathy was defined as hypoalbuminemia (serum albumin concentration of ≤3.2 g/dL) with one or more of the following signs or symptoms within the last six months: diarrhea, abdominal pain, peripheral edema, or facial edema. The U.S. Food and Drug Administration (FDA) granted the application for pozelimab fast track, orphan drug, and rare pediatric disease designations.

Society and culture

Legal status Pozelimab was approved for medical use in the United States in August 2023. The FDA granted the application for pozelimab fast track, priority review, and orphan drug designations.

Names Pozelimab is the international nonproprietary name.

References

External links Clinical trial number NCT04209634 for "Open-Label Efficacy and Safety Study of Pozelimab in Patients With CD55-Deficient Protein-Losing Enteropathy (CHAPLE Disease)" at ClinicalTrials.gov

Worked examples

Example 1 — a first encounter with Pozelimab

Start with the simplest possible case. Write down what Pozelimab claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In biology, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Pozelimab before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Pozelimab ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Pozelimab

In research: Pozelimab appears in biology research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Pozelimab in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Pozelimab is common in secondary-school and first-year university syllabi. It links to neighbouring topics Monoclonal antibodies, Orphan drugs, Regeneron Pharmaceuticals, so understanding it makes those chapters shorter.
In everyday life: Look for Pozelimab outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Pozelimab in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Pozelimab means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Pozelimab out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Pozelimab in simple terms?

Why does Pozelimab matter?

Because it connects several biology ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Pozelimab?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Pozelimab.